This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: National Cancer Center, Protanbio Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 264 
1 out of 1 Years Active: 2026
Title: Seongwon Hong: Innovator in Cancer Therapy
Introduction
Seongwon Hong is a notable inventor based in Goyang, South Korea. He has made significant contributions to the field of cancer therapy through his innovative work. His research focuses on developing advanced treatments that target specific cancer cells.
Latest Patents
Seongwon Hong holds a patent for a chimeric antigen receptor targeting BCMA and its use. This patent represents a crucial advancement in the treatment of certain types of cancers, particularly those affecting the blood.
Career Highlights
Throughout his career, Seongwon has worked with esteemed organizations such as the National Cancer Center and Protanbio Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field of oncology.
Collaborations
Seongwon has collaborated with notable colleagues, including Sangjin Lee and Hyeonseok Eom. These partnerships have fostered a productive environment for innovation and research in cancer therapies.
Conclusion
Seongwon Hong's contributions to cancer treatment through his patent and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for future advancements in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile